Zynrelef
Payments companies reported to CMS as associated with Zynrelef. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Zynrelef, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Zynrelef
These are the largest totals companies reported as associated with Zynrelef. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alan Rechter | Houston, TX | Orthopaedic Surgery | $273,476.37 |
| Randy Robbins | Plano, TX | Anesthesiology | $267,537.93 |
| Alexander Sah | Fremont, CA | Adult Reconstructive Orthopaedic Surgery | $143,966.71 |
| Scott Sigman | North Chelmsford, MA | Orthopaedic Surgery | $111,045.91 |
| Andrew Noble | Palm Beach Gardens, FL | Adult Reconstructive Orthopaedic Surgery | $106,350.44 |
| Russ Birdwell | Richardson, TX | Surgery | $65,234.91 |
| Eugene Viscusi | Philadelphia, PA | Anesthesiology | $64,832.62 |
| Russell Tigges | Poughkeepsie, NY | Adult Reconstructive Orthopaedic Surgery | $56,849.46 |
| Mark Mainous | Shreveport, LA | Surgical Critical Care | $56,648.61 |
| Michael Ashmore | Atlanta, GA | Anesthesiology | $52,964.87 |
Prescribed Zynrelef?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.